Document Detail


Preoperative prediction of mortality within 1 year after elective thoracic endovascular aortic aneurysm repair.
MedLine Citation:
PMID:  22840739     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Thoracic endovascular aortic repair (TEVAR) is known to have a survival benefit over open repair in patients with descending thoracic aneurysms and has become a mainstay of therapy. Because death before 1 year after TEVAR likely indicates an ineffective therapy, we have created a predictive model for death within 1 year using factors available in the preoperative setting.
METHODS: A registry of 526 TEVARs performed at the University of Florida between September 2000 and November 2010 was queried for patients with degenerative descending thoracic aneurysm as their primary pathology. Procedures with emergent or urgent indications were excluded. Preoperatively available variables, such as baseline comorbidities, anatomic-, and procedure-specific planning details, were recorded. Univariate predictors of death were analyzed with multivariable Cox proportional hazards to identify independent predictors of 30-day (death within 30 days) and 1-year mortality (death within 1 year) after TEVAR.
RESULTS: A total of 224 patients were identified and evaluated. The 30-day mortality rate was 3% (n = 7) and the 1-year mortality rate was 15% (n = 33). Multivariable predictors of 1-year mortality (hazard ratios [95% confidence interval]) included: age >70 years (5.8 [2.1-16.0]; P = .001), adjunctive intraoperative procedures (eg, brachiocephalic or visceral stents, or both, concomitant arch debranching procedures; 4.5 [1.9-10.8]; P = .001), peripheral arterial disease (3.0 [1.4-6.7]; P = .006), coronary artery disease (2.4 [1.1-4.9]; P = .02), and chronic obstructive pulmonary disease (1.9 [1.0-3.9]; P = .06). A diagnosis of hyperlipidemia was protective (0.4 [0.2-0.7]; P = .006). When patients were grouped into those with one, two, three, or four or more of these risk factors, the predicted 1-year mortality was 1%, 3%, 10%, 27%, and 54%, respectively.
CONCLUSIONS: Factors are available in the preoperative setting that are predictive of death within 1 year after TEVAR and can guide clinical decision making regarding the timing of repair. Patients with multiple risk factors, such as age ≥ 70 years, coronary artery disease, chronic obstructive pulmonary disease, and a need for an extensive procedure involving adjunctive therapies, have a high predicted mortality within 1 year and may be best served by waiting for a larger aneurysm size to justify the risk of intervention.
Authors:
Salvatore T Scali; Catherine K Chang; Robert J Feezor; Philip J Hess; Thomas M Beaver; Tomas D Martin; Thomas S Huber; Adam W Beck
Related Documents :
22544869 - Carotid-cavernous fistula treatment with ethylene vinyl alcohol (onyx) exclusively thro...
8356019 - Carotid, not aortic, chemoreceptors mediate the fetal cardiovascular response to acute ...
22692709 - Diving-related pulmonary oedema as an unusual presentation of alcoholic cardiomyopathy.
18817619 - Effects of endogenous sulfur dioxide on monocrotaline-induced pulmonary hypertension in...
22367649 - A proposed management algorithm for fistulae between hemodialysis access circuits and a...
19498269 - Time-dependent phenotypic and contractile changes of pulmonary artery in chronic hypoxi...
18342729 - Technical tips for thoracic aortic endografting.
14605779 - Asymptomatic liver segment herniation through a postoperative defect in the right hemid...
7217189 - Extra-anatomical approach to the congenital subclavian steal syndrome.
Publication Detail:
Type:  Journal Article     Date:  2012-07-25
Journal Detail:
Title:  Journal of vascular surgery     Volume:  56     ISSN:  1097-6809     ISO Abbreviation:  J. Vasc. Surg.     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-10-22     Completed Date:  2012-12-31     Revised Date:  2014-08-27    
Medline Journal Info:
Nlm Unique ID:  8407742     Medline TA:  J Vasc Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1266-72; discussion 1272-3     Citation Subset:  IM    
Copyright Information:
Copyright © 2012 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aortic Aneurysm, Thoracic / mortality*,  surgery*
Endovascular Procedures*
Female
Humans
Male
Middle Aged
Prognosis
Prospective Studies
Risk Assessment
Surgical Procedures, Elective
Survival Rate
Time Factors
Grant Support
ID/Acronym/Agency:
K23 HL115673/HL/NHLBI NIH HHS
Comments/Corrections
Comment In:
J Vasc Surg. 2013 Apr;57(4):1176   [PMID:  23535047 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Comparison of vein valve function following pharmacomechanical thrombolysis vs simple catheter-direc...
Next Document:  The role of dynamic contrast-enhanced magnetic resonance imaging in the diagnosis and management of ...